Nav: Home

Geneticist Stephen J. Elledge wins Breakthrough Prize

December 04, 2016

Stephen J. Elledge, the Gregor Mendel Professor of Genetics at Brigham and Women's Hospital and Harvard Medical School, has been named a 2017 recipient of the Breakthrough Prize, which recognizes paradigm-shifting discoveries in the life sciences, physics, and mathematics.

Elledge is being honored for his wide-ranging contributions across multiple fields in biology. His work has elucidated critical mechanisms in cell division, cell aging, cancer growth and protein breakdown and recycling.

The Breakthrough Prize -- said to be the largest in the world for science -- includes a $3 million award for each recipient and will be celebrated during a televised gala at the NASA Ames Research Center in Silicon Valley and broadcast live on the National Geographic channel on Sunday, Dec. 4, at 10 p.m. E.T.

"This magnificent award is a fitting recognition and acknowledgement of Stephen's outstanding ingenuity, tenacity and vision," said Elizabeth G. Nabel, president of Brigham and Women's Health Care. "We are extremely fortunate to count him among our colleagues here at Brigham and Women's, and congratulate him and this year's other prize winners on their remarkable achievements."

One of Elledge's most pivotal discoveries is unraveling the process by which cells sense DNA damage and initiate self-repair, a critical fail-safe mechanism that safeguards both individual cells and the integrity and health of the entire organism.

DNA, which forms the basis of life, fends off constant damage from various sources, including normal metabolic byproducts, environmental toxins, sunlight and normal aging. Such assaults can alter DNA's chemical structure, leaving behind changes, or mutations, in the cell's genetic code. If left unrepaired, these alterations can disrupt key biological processes, leading to serious diseases, including cancer.

A cell's failure to sense the presence of aberrations in its DNA can spark cancerous mutations and malignant cell proliferation.

Elledge's work revealed that a "watchdog" protein-enzyme pair sniff out damaged DNA and send a message to the cell's internal repair machinery to fix the problem. If and when the cell fails to mend its broken DNA, it issues a command to self-destroy. This process, known as cell suicide, or apoptosis, is the body's way of stemming the proliferation of abnormal cells and preventing cancer. Elledge's discoveries explained how and why this mechanism sometimes fails.

Cancer development is an astoundingly complex process. It is the end result of a series of failures in the cell's ability to detect, repair and halt DNA damage.

Unraveling the intricacies of cell behavior in response to DNA stress has been one of the most vexing challenges in genetics, oncology and, indeed, modern medicine. It is also one that holds great therapeutic hope for cancer. Elledge's discoveries explain one of the key steps in this process, and in doing so it sheds light on one of the long-standing mysteries in cancer genomics: Why and how cells sometimes fail to sense the presence of DNA malfunction.

"Stephen's work toward elucidating the way cells sense DNA damage and initiate self-repair is breathtaking in its scope and elegance," said Barbara McNeil, acting dean of Harvard Medical School. "His passion for discovery, his curiosity and creativity embody the spirit of Harvard Medical School and the noblest traditions in scientific thought and inquiry. This award is a testament to that."

Elledge made his initial observations about DNA damage in yeast while working as a postdoctoral student at Stanford University in the late 1980s. He noticed that levels of a certain enzyme spiked when yeast DNA was damaged or failed to copy itself properly. Speculating that the same enzymatic "alert" mechanism may be at play in the cells of mammals and humans, Elledge relentlessly pursued that notion for the next 20 years.

Working with collaborators from several other institutions, Elledge went on to devise genetic models to test that concept in mammalian and human cells. He went on to describe, step by step, the signaling pathway that regulates the cell's response to DNA damage stress and, ultimately, to identify the central characters that regulate this elaborate, yet elegant, protective mechanism.

Elledge's scientific pursuits culminated in the discovery in the early 2000s of a pair of protein-kinase complexes that engage in an intricate interplay to detect DNA damage, notify one another of its presence and, ultimately, alert the cell's "central command" to the presence of damaged DNA.

"Steve is not only a primary founder of the DNA damage surveillance and response field, he has been its intellectual leader. He has shown the courage to move where the science demands that he move," said Gary Ruvkun, professor of Genetics at Harvard Medical School and Massachusetts General Hospital, a winner of the Breakthrough Prize in Life Sciences in 2015, and a member of the current selection committee for the 2017 prize. "Further, he has consistently promoted novel genetic technologies that have had a profound impact on research by many labs, including his own."

Elledge has applied basic principles of mathematics to design technologies that can analyze massive gene databases to help identify candidate genes that may play a role in cancer and autoimmune disorders.

More recently, harnessing the power of proteomics and computational analysis, Elledge and colleagues designed a new method to track the footprints of every single virus a person has been exposed to in a lifetime. That knowledge could help illuminate new understanding of the long-term consequences of past viral encounters and elucidate the role that viruses may play in the development of disorders ranging from cancer to autoimmune diseases to neurodegenerative conditions.

"I'm truly honored to receive the Breakthrough Prize," Elledge said. "It is deeply gratifying to see the profound impact that basic research can have not only in promoting scientific knowledge but also in improving human health."

Elledge plans to apply a significant portion of the funds he receives through the Breakthrough Prize toward philanthropic causes, which will include efforts to promote secondary and higher education with an emphasis on science.

Elledge is a Howard Hughes Medical Institute investigator and member of the Institute of Medicine and the National Academy of Sciences. He is the recipient of numerous awards, including the 2015 Albert Lasker Basic Medical Research Award, the National Academy of Sciences Award in Molecular Biology, the Genetics Society of America Medal, the Paul Marks Prize for Cancer Research and the Dickson Prize in Medicine, among others.

Now in its fifth year, the Breakthrough Prize was founded by Sergey Brin and Anne Wojcicki, Jack Ma and Cathy Zhang, Mark Zuckerberg and Priscilla Chan, and Yuri and Julia Milner. Winners are selected by a committee drawn from past Breakthrough Prize laureates.
-end-


Brigham and Women's Hospital

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#541 Wayfinding
These days when we want to know where we are or how to get where we want to go, most of us will pull out a smart phone with a built-in GPS and map app. Some of us old timers might still use an old school paper map from time to time. But we didn't always used to lean so heavily on maps and technology, and in some remote places of the world some people still navigate and wayfind their way without the aid of these tools... and in some cases do better without them. This week, host Rachelle Saunders...
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.